Zimmer Biomet Holdings (ZBH) and LDR Holding Corp (LDRH) Financial Contrast

Zimmer Biomet Holdings (NYSE: ZBH) and LDR Holding Corp (NASDAQ:LDRH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Institutional and Insider Ownership

85.4% of Zimmer Biomet Holdings shares are owned by institutional investors. 1.1% of Zimmer Biomet Holdings shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.


This table compares Zimmer Biomet Holdings and LDR Holding Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zimmer Biomet Holdings 8.36% 16.29% 6.17%
LDR Holding Corp -18.02% -16.37% -13.65%

Valuation & Earnings

This table compares Zimmer Biomet Holdings and LDR Holding Corp’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Zimmer Biomet Holdings $7.68 billion 2.93 $305.90 million $3.18 34.92
LDR Holding Corp N/A N/A N/A ($0.71) -52.08

Zimmer Biomet Holdings has higher revenue and earnings than LDR Holding Corp. LDR Holding Corp is trading at a lower price-to-earnings ratio than Zimmer Biomet Holdings, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Zimmer Biomet Holdings and LDR Holding Corp, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet Holdings 1 6 14 1 2.68
LDR Holding Corp 0 0 0 0 N/A

Zimmer Biomet Holdings currently has a consensus price target of $135.40, indicating a potential upside of 21.92%. Given Zimmer Biomet Holdings’ higher probable upside, research analysts plainly believe Zimmer Biomet Holdings is more favorable than LDR Holding Corp.


Zimmer Biomet Holdings pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. LDR Holding Corp does not pay a dividend. Zimmer Biomet Holdings pays out 30.2% of its earnings in the form of a dividend.


Zimmer Biomet Holdings beats LDR Holding Corp on 11 of the 12 factors compared between the two stocks.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company’s product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

LDR Holding Corp Company Profile

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply